Original Research
Published on 24 Jan 2023
A novel defined TLR3 agonist as an effective vaccine adjuvant
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1075291
- 7,350 views
- 15 citations
Type at least 3 characters
2,749 articles
Articles
Original Research
Published on 24 Jan 2023
Adenovirus vector-mediated single chain variable fragments target the nucleocapsid protein of porcine epidemic diarrhea virus and protect against viral infection in piglets
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1058327
- 3,884 views
- 2 citations
Brief Research Report
Published on 24 Jan 2023
Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.1044025
- 2,213 views
- 2 citations
Brief Research Report
Published on 23 Jan 2023
SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despite low neutralizing antibody responses
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.941281
- 3,012 views
- 4 citations
Systematic Review
Published on 23 Jan 2023
Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1116738
- 2,484 views
- 10 citations
Review
Published on 23 Jan 2023
Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.1038226
- 7,312 views
- 22 citations
Original Research
Published on 20 Jan 2023
Assessment of the longitudinal humoral response in non-hospitalized SARS-CoV-2-positive individuals at decentralized sites: Outcomes and concordance
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.1052424
- 1,787 views
- 2 citations
Original Research
Published on 20 Jan 2023
Targeting HIV-1 reservoirs in T cell subsets
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1087923
- 3,830 views
- 2 citations
Review
Published on 19 Jan 2023
Review: Current trends, challenges, and success stories in adjuvant research
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1105655
- 5,336 views
- 17 citations
Original Research
Published on 19 Jan 2023
A bacterial outer membrane vesicle-based click vaccine elicits potent immune response against Staphylococcus aureus in mice
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1088501
- 3,989 views
- 9 citations
Brief Research Report
Published on 19 Jan 2023
Age-adjusted impact of prior COVID-19 on SARS-CoV-2 mRNA vaccine response
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1087473
- 2,362 views
- 1 citation
Correction
Published on 19 Jan 2023
Corrigendum: Suitability of potyviral recombinant virus-like particles bearing a complete food allergen for immunotherapy vaccines
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1133046
- 815 views
Original Research
Published on 19 Jan 2023
The adjuvant effect of bacterium-like particles depends on the route of administration
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1082273
- 2,674 views
- 6 citations
Perspective
Published on 18 Jan 2023
Engineered soluble ACE2 receptor: Responding to change with change
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.1084331
- 2,009 views
- 6 citations
Original Research
Published on 18 Jan 2023
Mycobacterium avium subsp. paratuberculosis antigens induce cellular immune responses in cattle without causing reactivity to tuberculin in the tuberculosis skin test
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.1087015
- 3,872 views
- 2 citations
Original Research
Published on 18 Jan 2023
Patients with IBD have a more cautious attitude towards COVID-19 vaccination
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.1077308
- 1,686 views
- 5 citations